Literature DB >> 335606

Serum antibody titers in urethritis and chronic bacterial prostatitis.

E M Meares.   

Abstract

Serum antibody titers were measured by direct bacterial agglutination technique against various strains of Escherichia coli found in the fecal flora of a control group of men who had no history of genitourinary tract infection, against the strains of E. coli responsible for urethral infection in 7 men with urethritis, and against the strains of E. coli responsible for prostatic infection in 25 men with chronic prostatitis. Low serum titers were found in both the control group (median titer of 1:20) and in the urethritis group (median titer of 1:10). Excluding 3 men who had self-agglutinating strains, 18 of 22 (82 per cent) in the prostatitis group had serum titers of 1:320 or greater (median titer of 1:640). Measurement of serum antibody titers by this technique can be a valuable adjunct to diagnosis in cases of chronic prostatitis due to strains of E. coli.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 335606     DOI: 10.1016/0090-4295(77)90155-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  Prostatitis: diagnosis and treatment.

Authors:  E M Meares
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model.

Authors:  C Jantos; M Altmannsberger; W Weidner; H G Schiefer
Journal:  Urol Res       Date:  1990

3.  Use of a solid-phase radioimmunoassay and formalin-fixed whole bacterial antigen in the detection of antigen-specific immunoglobulin in prostatic fluid.

Authors:  L M Shortliffe; N Wehner; T A Stamey
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 4.  Chronic bacterial prostatitis: theoretical and experimental considerations.

Authors:  P O Madsen; K M Jensen; P Iversen
Journal:  Urol Res       Date:  1983

Review 5.  Prostatitis.

Authors:  T A Stamey
Journal:  J R Soc Med       Date:  1981-01       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.